Welcome to our Member Spotlight series where we give a profile overview of our many diverse members. For this deep dive, we spoke to Deepak Gupta, Managing Partner at Blue Bear Ventures.
Sarepta Therapeutics will pay GenEdit up to $57 million in the near-term for access to the
